PPF60 Re-audit of oxygen prescribing and monitoring in a hospice setting following establishment of electronic prescribing

Read full text Summarise with VIRAT
Authors: Rozalind Whitaker, Athea Ashley, Jennie Pickard, Alison Phippen, Damian Lacey, Olivia Roberts, James Humphries, Amy Walkley, Lesley Anne Henson, Samantha Kay
Cited by: 0
References: 2

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction In palliative care, oxygen therapy can be used for the treatment of hypoxia and/or for symptomatic relief of breathlessness (O’Driscoll, 2017). We conducted a re-audit of hospice inpatient oxygen prescribing and monitoring following establishment of an electronic prescribing system. Methods Data was collected retrospectively for all hospice inpatients who received oxygen therapy between April and July 2025. We measured data against 23 standards identified from the British Thoracic Society 2017 guidelines and three hospice policies (Medical Gases Policy 2024; Oxygen Standard Operating Procedure 2025; Medicine Policy 2022). Standards were grouped into four categories, those relating to oxygen prescribing (n=10), oxygen monitoring (n=6), medical review (n=5) and risk assessment (n=2). Target rates for each standard were 100%. Results were compared with 2023 audit findings when paper prescribing and monitoring were in place. For each patient, mean concordance was calculated as a percentage score for the four categories of standards. Results 68 patients received oxygen therapy and were included in the audit. Of these, 59 had an oxygen prescription. Among the ten prescribing standards, only one achieved 100% completion, the requirement for prescriptions to be signed. This was assured by the switch to electronic prescribing. 51% of prescriptions (n=40) had an appropriate oxygen flowrate, device and target saturations recorded, compared with 59% in 2023 (n=44). Oxygen monitoring had worsened from the 2023 audit with infrequent documentation of oxygen flowrates (22% vs 51% in 2023), devices (19% vs 51%) and saturations (20% vs 24%). Mean concordance with standards were: 68% for prescribing practice; 25% for monitoring; 41% for medical review; and, 63% for risk assessment. Conclusion Establishment of an electronic prescribing system has not improved oxygen therapy prescribing or monitoring for hospice inpatients. Recommendations are to improve the prescribing template and monitoring proforma within the electronic prescribing software. References O’Driscoll BR, et al. British Thoracic Society guideline for oxygen use in adults in healthcare and emergency settings. Thorax 2017;72(Suppl 1):ii1–ii90. doi: 10.1136/thoraxjnl-2016-209729. Lomax P. (2024), Moya Cole Hospice: Medical Gas Policy, Version 3. Lacey D. (2025), Moya Cole Hospice SOP: Procedure for managing patients with Oxygen Therapy, Version 1. Pickard J. (2022), Moya Cole Hospice: Medicine Policy Version 2.1.

Fields of Study & Subjects

Palliative Care and End-of-Life Issues Electronic Health Records Systems Pain Management and Opioid Use

Publication details

Journal / source
BMJ Supportive & Palliative Care
Pages
A66.2–A66
Publication date
25 March 2026
Language
EN